March 25, 2020 at 03:23AM Statement on data accuracy issues with recently approved gene therapy

Statement by Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research, on data accuracy issues with recently approved gene therapy

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2YQCRGE